Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The present project aims at comparing two nonmyeloablative regimens currently used in 2 major
HCT centers in the US for patients with HLA-matched related or unrelated donor: the one from
the Seattle group consisting of 2 Gy TBI with fludarabine (90 mg/m²) versus the one from the
Stanford group combining 8 Gy TLI with ATG.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital of Liege University of Liege
Collaborators:
Katholieke Universiteit Leuven KU Leuven Maastricht University Medical Center